Introduction
============

Besides intracranial pressure (ICP) monitoring, brain tissue oxygenation (p~bt~O~2~) monitoring with the Licox system (Integra Neuroscience, Germany) is on the verge of clinical routine in acute brain injury. Recently, a new p~bt~O~2~probe by a different manufacturer (Raumedic AG, Germany) was introduced into the market. As this new probe facilitates measurement of ICP as well, its use would reduce invasiveness of multimodal neuromonitoring. Therefore, we investigated the agreement of p~bt~O~2~values of both probes in patients with aneurysmal subarachnoid hemorrhage necessitating ICP and p~bt~O~2~monitoring.

Methods
=======

Eight patients with p~bt~O~2~monitoring probes of both types implanted side by side in the same vascular territory were investigated. Multimodal monitoring data were stored online with dedicated software. Data were analyzed using the method proposed by Bland and Altman \[[@B1]\].

Results
=======

The mean measurement time per patient was 8.6 days. All data pooled, the mean bias was -0.66 mmHg. The precision range (two standard deviations of the bias) was -32.9 to 32.6 mmHg. The Licox probe showed a tendency for higher values at high p~bt~O~2~, while the Raumedic probe showed higher values at low p~bt~O~2~. Analysis of single patients revealed no discernible pattern in the relationship of measurement values of both probes. Three of the new probes ceased to function prematurely.

Conclusion
==========

Our data suggest that measurements of both p~bt~O~2~probes cannot be interchanged. No easy algorithm for conversion of measurement data from one system to the other is available. More rigorous bench testing is necessary before implementation of the new system in the clinical routine.
